Harrison SL - Search Results

1

Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry.

Joddrell M, El-Bouri W, Harrison SL, Huisman MV, Lip GYH, Zheng Y; GLORIA-AFinvestigators. Joddrell M, et al. Among authors: harrison sl. Sci Rep. 2024 Nov 7;14(1):27088. doi: 10.1038/s41598-024-78120-z. Sci Rep. 2024. PMID: 39511367 Free PMC article.

2

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review.

Stevens D, Harrison SL, Kolamunnage-Dona R, Lip GYH, Lane DA. Stevens D, et al. Among authors: harrison sl. Europace. 2021 Oct 9;23(10):1511-1527. doi: 10.1093/europace/euab092. Europace. 2021. PMID: 34125202 Free PMC article. Review.

3

Revisiting the dynamic risks of incident atrial fibrillation: does the use of nonsteroidal anti-inflammatory drugs contribute to risk?

Harrison SL, O'Flaherty M, Lip GYH. Harrison SL, et al. QJM. 2020 Feb 1;113(2):77-78. doi: 10.1093/qjmed/hcz310. QJM. 2020. PMID: 31769849 No abstract available.

4

Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes.

Harrison SL, Lane DA, Lip GYH. Harrison SL, et al. Eur J Heart Fail. 2020 Jan;22(1):136-138. doi: 10.1002/ejhf.1685. Epub 2019 Dec 9. Eur J Heart Fail. 2020. PMID: 31820530 Free article. No abstract available.

5

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies.

Ding WY, Harrison S, Gupta D, Lip GYH, Lane DA. Ding WY, et al. Front Med (Lausanne). 2020 Feb 21;7:54. doi: 10.3389/fmed.2020.00054. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32154260 Free PMC article. Review.

6

Considerations when choosing an appropriate bleeding risk assessment tool for patients with atrial fibrillation.

Ding WY, Harrison SL, Lane DA, Lip GYH. Ding WY, et al. Among authors: harrison sl. J Thromb Haemost. 2020 Apr;18(4):788-790. doi: 10.1111/jth.14738. J Thromb Haemost. 2020. PMID: 32233026 Free article. No abstract available.

7

Atrial fibrillation and the risk of 30-day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID-19.

Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GYH. Harrison SL, et al. J Arrhythm. 2020 Dec 11;37(1):231-237. doi: 10.1002/joa3.12458. eCollection 2021 Feb. J Arrhythm. 2020. PMID: 33664908 Free PMC article.

8

Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications.

Harrison SL, Buckley BJR, Lane DA, Underhill P, Lip GYH. Harrison SL, et al. Pharmacol Res. 2021 May;167:105534. doi: 10.1016/j.phrs.2021.105534. Epub 2021 Mar 4. Pharmacol Res. 2021. PMID: 33677103 Free PMC article.

9

Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management.

Harrison SL, Akpan A, Lip GYH. Harrison SL, et al. J Am Geriatr Soc. 2021 Jul;69(7):1807-1810. doi: 10.1111/jgs.17142. Epub 2021 Apr 24. J Am Geriatr Soc. 2021. PMID: 33893638 No abstract available.

10

Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review.

Ritchie LA, Oke OB, Harrison SL, Rodgers SE, Lip GYH, Lane DA. Ritchie LA, et al. Among authors: harrison sl. Age Ageing. 2021 May 5;50(3):744-757. doi: 10.1093/ageing/afaa268. Age Ageing. 2021. PMID: 33951148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters